Ro3280 → 4-(9-cyclopentyl-7-fluoro-5-methyl-6-oxo-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,4]diazepin-2-ylamino)-3-methoxy-N-(1-methylpiperidin-4-yl)benzamide

HRID 1880910노트

반응식

[CH:1]1([N:6]2[CH2:12][C:11](F)([F:13])[C:10](=[O:15])[N:9]([CH3:16])[C:8]3[CH:17]=[N:18][C:19]([NH:21][C:22]4[CH:37]=[CH:36][C:25]([C:26]([NH:28][CH:29]5[CH2:34][CH2:33][N:32]([CH3:35])[CH2:31][CH2:30]5)=[O:27])=[CH:24][C:23]=4[O:38][CH3:39])=[N:20][C:7]2=3)[CH2:5][CH2:4][CH2:3][CH2:2]1.FC(C([O-])=O)CN>>[CH:1]1([N:6]2[CH2:12][CH:11]([F:13])[C:10](=[O:15])[N:9]([CH3:16])[C:8]3[CH:17]=[N:18][C:19]([NH:21][C:22]4[CH:37]=[CH:36][C:25]([C:26]([NH:28][CH:29]5[CH2:34][CH2:33][N:32]([CH3:35])[CH2:31][CH2:30]5)=[O:27])=[CH:24][C:23]=4[O:38][CH3:39])=[N:20][C:7]2=3)[CH2:2][CH2:3][CH2:4][CH2:5]1

참가 물질

반응물 2

HCID 25015677Ro3280

HCID 866358932-Fluoro-beta-alaninate

생성물 1

HCID 252551064-(9-cyclopentyl-7-fluoro-5-methyl-6-oxo-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,4]diazepin-2-ylamino)-3-methoxy-N-(1-methylpiperidin-4-yl)benzamide

실험 절차

The title compound was synthesized using an analogous procedure to that described in connection with Compound 3 except that 2-fluoro-beta-alaninate was used as the starting material. The final product was purified on reversed phase HPLC as TFA salt. 1H NMR (400 MHz, DMSO-d6) δ ppm 1.55-1.87 (m, 11 H) 1.91-2.08 (m, 3 H) 2.18 (s, 3 H) 2.79 (d, J=11.4 Hz, 2 H) 3.24 (s, 3 H) 3.61-3.83 (m, 3 H) 3.94 (s, 3 H) 4.77 (quin., J=8.3 Hz, 1 H) 5.52 (qd, 1 H) 7.47 (dd, J=1.8 Hz, 1 H) 7.49 (s, 1 H) 7.86 (s, 1 H) 8.11 (d, J=7.8 Hz, 1 H) 8.16 (s, 1 H) 8.33 (d, J=8.34 Hz, 1 H). [M+H] calc'd for C27H36FN7O3 526; found 526.

후처리

customThe final product was purified on reversed phase HPLC as TFA salt

출처 및 근거

ORD 기록: ord-a52df4f994de4ffbadd7af3982ee564d
출처 데이터셋: uspto-grants-2012_11
DOI: 10.6084/m9.figshare.5104873.v1
특허 번호: US08318727B2

반응 노트

불러오는 중…